ZFP
Navigation Links
ZFP in Medical News
Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009
Analysis of Subjects with Moderately Severe Diabetic Neuropathy Shows Statistically Significant Improvement in Multiple Quantitative Neurological Endpoints RICHMOND, Calif., June 8 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of as y...Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference
...ill provide an update on the progress of Sangamo's zfp Therapeutic(TM) development programs and an overvi...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...Sangamo BioSciences Reports First Quarter 2009 Financial Results
...n in Nature of the successful application of zfp technology for the efficient generation of maize p...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives
...ve had together to confirm our conviction that the zfp platform has the ability to truly transform the fi... Mr. Peribere. "We have established that Sangamo's zfp technology can be used to regulate and modify gene... clinical data from our Phase 1b trial of our lead zfp Therapeutic(TM), SB-509, an activator of vascular ...Sangamo BioSciences to Present at the ThinkEquity Partners Growth Conference
...ill provide an update on the progress of Sangamo's zfp Therapeutic development programs and an overview o...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... Phase 1 clinical trials are ongoing to evaluate a zfp Therapeutic for peripheral artery disease. Other t...New Gene Therapy Treats Diabetic Neuropathy
...Faculty of Life Sciences. ‘Our approach to gene therapy is quite different to previous attempts at treatment: we use a DNA-binding protein called zfp TFTM to poke life into the patient's own genes and produce a growth factor that has a role in nerve protection and regeneration. ‘As the data in ...ZFP in Medical Technology
Presentation Details Statistically Significant and Clinically Relevant
Results for SB-509 in Development for Treatment of Diabetic Neuropathy
SAN FRANCISCO, June 8 /PRNewswire-FirstCall/ -- Sangamo BioSciences,
Inc. (Nasdaq: SGMO ) announced today the presentation of encouraging Phase
1b ...
ZFN Modified Cells Show Glioblastoma Killing in the Presence of Dexamethasone in Mouse Tumor Model SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced the presentation of positive data in a mouse tumor model from its ZF...
Milestone Triggers Payment to Sangamo from JDRF RICHMOND, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that the company has completed enrollment of its randomized, double-blind, repeat-dosing, placebo-controlled, multi-center P...
Statistically Significant Improvements in Function in Spinal Cord Injury Model With ZFP TF Treatment RICHMOND, Calif., May 03, 2007 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today the presentation of preclinical data from its ZFP Therapeutic(TM) program in nerve regeneration at...
...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. The most advanced zfp Therapeutic(TM) development program is currently i...
...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. Sangamo...
...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... Phase 1 clinical trials are ongoing to evaluate a zfp Therapeutic for peripheral artery disease. Other t...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. Sangamo...
ZFN Modified Cells Show Glioblastoma Killing in the Presence of Dexamethasone in Mouse Tumor Model SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced the presentation of positive data in a mouse tumor model from its ZF...
Milestone Triggers Payment to Sangamo from JDRF RICHMOND, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that the company has completed enrollment of its randomized, double-blind, repeat-dosing, placebo-controlled, multi-center P...
Statistically Significant Improvements in Function in Spinal Cord Injury Model With ZFP TF Treatment RICHMOND, Calif., May 03, 2007 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. announced today the presentation of preclinical data from its ZFP Therapeutic(TM) program in nerve regeneration at...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro......ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. The most advanced zfp Therapeutic(TM) development program is currently i...
Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
...ill provide an update on the progress of Sangamo's zfp Therapeutic(TM) development programs and an overvi...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
... in laboratories worldwide and we expect Sangamo's zfp technology to be nothing short of revolutionary fo...past year has been a year of real progress for our zfp technology platform," said Edward Lanphier, presid...us to make significant progress in moving our lead zfp Therapeutic into multiple Phase 2 clinical trials ......ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. Sangamo...
...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... Phase 1 clinical trials are ongoing to evaluate a zfp Therapeutic for peripheral artery disease. Other t...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. Sangamo...
ZFP in Biological News
Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection
Sangamo BioSciences, Inc. today announced that data from its program to develop a ZFP Therapeutic for HIV/AIDS were presented at the 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Washington, DC. The study represents the first demonstration that cells can b...Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference
...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... Phase 1 clinical trials are ongoing to evaluate a zfp Therapeutic for peripheral artery disease. Other t...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TFTM) that can control ...Trial success for diabetic nerve therapy
...s Faculty of Life Sciences. "Our approach to gene therapy is quite different to previous attempts at treatment: we use a DNA-binding protein called zfp TFTM to poke life into the patient's own genes and produce a growth factor that has a role in nerve protection and regeneration. "As the data in th...ZFP in Biological Technology
Progenitor Cell Mobilization Observed in Subjects with Critical Limb Ischemia Treated with ZFP Therapeutic
MIAMI, May 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc.
(Nasdaq: SGMO ) announced today the presentation of data from a Phase 1
clinical trial of a zinc finge...
RICHMOND, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced that it had entered into a License Agreement with Open Monoclonal Technologies (OMT), a private company based in Palo Alto, California. Under this agreement, Sangamo will provid...
Companies Agree to Expanded Access to ZFN Technology To Potentially Improve Protein Production RICHMOND, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced that it has entered into a second Research and License Agreement...
Statistically Significant Improvements in Function and Tissue Preservation with ZFP TF Treatment in Spinal Cord Injury Model SAN DIEGO, Nov. 7 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of preclinical data from its ZFP Therape...
...valuate the safety and tolerability of SB-728-T, a zfp Therapeutic based on Sangamo's CCR5-disrupting ZFN...our efforts to develop the next generation of this zfp Therapeutic, an in-vivo formulation for direct i...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i...
...Sangamo demonstrated the successful application of zfp technology for the efficient generation of maize p... , scientists at Dow AgroSciences and Sangamo used zfp Nucleases (ZFNs(TM)) to introduce a herbicide tole...ul demonstration of the broad applicability of our zfp technology platform," stated Philip Gregory, D. Ph...
RICHMOND, Calif., April 7, 2008 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced that it had entered into a License Agreement with Open Monoclonal Technologies (OMT), a private company based in Palo Alto, California. Under this agreement, Sangamo will provid...
Companies Agree to Expanded Access to ZFN Technology To Potentially Improve Protein Production RICHMOND, Calif., Feb. 27 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) today announced that it has entered into a second Research and License Agreement...
Statistically Significant Improvements in Function and Tissue Preservation with ZFP TF Treatment in Spinal Cord Injury Model SAN DIEGO, Nov. 7 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the presentation of preclinical data from its ZFP Therape...
Sangamo BioSciences Reports Second Quarter 2009 Financial Results
...hlights Presentation of positive Phase 2 zfp Therapeutic data at ADA 2009. Sangamo announced t...unreleased positive Phase 2 clinical data from its zfp Therapeutic(TM) program to develop SB-509 as a tre...angamo demonstrating the successful application of zfp technology for the efficient generation of maize p...Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...tion. Sangamo is also developing sequence-specific zfp Nucleases (ZFN(TM)) for gene modification. The most advanced zfp Therapeutic(TM) development program is currently i...Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
...ill provide an update on the progress of Sangamo's zfp Therapeutic(TM) development programs and an overvi...ene regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t......valuate the safety and tolerability of SB-728-T, a zfp Therapeutic based on Sangamo's CCR5-disrupting ZFN...our efforts to develop the next generation of this zfp Therapeutic, an in-vivo formulation for direct i...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i...
...Sangamo demonstrated the successful application of zfp technology for the efficient generation of maize p... , scientists at Dow AgroSciences and Sangamo used zfp Nucleases (ZFNs(TM)) to introduce a herbicide tole...ul demonstration of the broad applicability of our zfp technology platform," stated Philip Gregory, D. Ph...
Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
...ne regulation and modification. The most advanced zfp Therapeutic(TM) development program is currently i... trial to evaluate safety and clinical effect of a zfp Therapeutic for the treatment of HIV/AIDS. Other t...ognize a specific DNA sequence Sangamo has created zfp transcription factors (ZFP TF(TM)) that can contro...Other TagsCannabinoidOther Contentsoropharynxorthopedicsimperfectaosteoarthritisosteoarthritisosteoarthritisosteoarthritis
CeftazidimeCefazolinCatecholaminesFractionatedCatecholaminesCarotenesCaroteneCarisoprodolCardizemCardioquinCarboxyhemoglobinCarbolicCarbidopaCanrenoneCannabinoid
(Date:12/1/2009)...jor Peer Review Journals Have Identified The PADDS... The Evidence-Based Assessment Of Attention And Ex... Recent Are Listed Below. , ...Leesa V. Huang Ph.D. for the Journal of Attention...e synopsis of this article is available on PubMed...
(Date:12/1/2009)...RNewswire/ -- To date, hospitals have not found a ... the $20 cost of the disposable sensor for your br...nesthesiologists have not told hospitals how impor...from routine anesthesia over-medication. ,, Ane...cation, message from their leaders because their o...
(Date:12/1/2009)...ography screening may increase breast cancer risk ...o breast cancer, according to a study presented to...ety of North America (RSNA). , "For women at hi...tant, but a careful approach should be taken when ... particularly under age 30," said Marijke C. Janse...
(Date:12/1/2009)...ead to early degeneration in the spine, according ...f the Radiological Society of North America (RSNA)...ion between increased body mass index (BMI) and di...ad author, Judah G. Burns, M.D., fellow in diagnos...ontefiore in New York City. , In this retrospec...
(Date:11/30/2009)...sults of a randomized, controlled clinical trial p...ogical Society of North America (RSNA) reveal that...n arteries that supply blood to the legs and other...t coronary artery disease. ,, Peripheral arter...n of fat, cholesterol and other substances, builds...
Breaking Medicine News(10 mins):Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 2Health News:Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:Mammography may increase breast cancer risk in some high-risk women 2Health News:Overweight children may develop back pain and spinal abnormalities 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 2Health News:Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries 3[0] Targeted Testing Receives Favorable Reviews On PADDS, Begins Nationwide Research Study On The Target Tests of Executive Functioning-OV[0] 5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed[0] Mammography may increase breast cancer risk in some high-risk women[0] Overweight children may develop back pain and spinal abnormalities[1] Severe Asymptomatic Heart Disease May Accompany Narrowing in Leg Arteries
(Date:11/25/2009)...ptember 11, firefighters, police officers and ambu...the World Trade Center complex. They battled to sa...d for survivors, tackled fires and evacuated as ma... an estimated 17,000 people. And making their jobs...s: frightened workers and their relatives jammed m...
(Date:11/25/2009)...the course of a lifetime, the heart pumps some 250...order to do this, the muscle fibers of the heart h...aded by Dr. Wolfgang Rottbauer, vice chair of the ...y Hospital (Chairman: Prof. Dr. H. A. Katus), has ...tability of the smallest muscular unit, the sarcom...
(Date:11/24/2009)...housands of years it has been prescribed by tradit...ts from headaches and stomach pain to fever and fl...stle University have been able to scientifically p...ata otherwise known as Brazilian mint. , Testin...am led by researcher Graciela Rocha was able to sh...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2Pamela Lyon M D Achieves Board Certification in Bariatric Weight Loss Medicine 48400 1Pamela Lyon M D Achieves Board Certification in Bariatric Weight Loss Medicine 48400 2New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 1New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 2New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 3New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 4New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 5New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives 12549 6Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 1Naps with rapid eye movement sleep increase receptiveness to positive emotion 48396 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |